A new prevention paradox: the trade-off between reducing incentives for risk selection and increasing the incentives for prevention for health insurers
- PMID: 23182593
- DOI: 10.1016/j.socscimed.2012.10.019
A new prevention paradox: the trade-off between reducing incentives for risk selection and increasing the incentives for prevention for health insurers
Abstract
The Dutch risk equalization scheme has been improved over the years by including health related risk adjusters. The purpose of the Dutch risk equalization scheme is to prevent risk selection and to correct for predictable losses and gains for insurers. The objective of this paper is to explore the financial incentives for risk selection under the Dutch risk equalization scheme. We used a simulation model to estimate lifetime health care costs and risk equalization contributions for three cohorts (a smoking; an obese; and a healthy living cohort). Financial differences for the three cohorts were assessed by subtracting health care costs from risk equalization contributions. Even under an elaborate risk equalization system, the healthy living cohort was still most financially attractive for insurers. Smokers were somewhat less attractive, while the obese cohort was least attractive. Lifetime differences with healthy living individuals (revenues minus costs) were modest: €4840 for obese individuals and €1101 for smokers. Under a simple form of risk equalization these differences were higher, €8542 and €4620 respectively. Improvement of the risk equalization scheme reduced the gap between costs and revenues. Incentives for undesirable risk selection were reduced, but simultaneously incentives for health promotion were weakened. This highlights a new prevention paradox: improving the level playing field for health insurers will inevitably limit their incentives for promoting the health of their clients.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Optimal cost reimbursement of health insurers to reduce risk selection.Health Econ. 2011 May;20(5):532-52. doi: 10.1002/hec.1614. Health Econ. 2011. PMID: 20572200
-
Improving risk equalization using multiple-year high cost as a health indicator.Med Care. 2012 Feb;50(2):140-4. doi: 10.1097/MLR.0b013e31822ebf8b. Med Care. 2012. PMID: 21945975
-
Risk equalization in The Netherlands: an empirical evaluation.Expert Rev Pharmacoecon Outcomes Res. 2013 Dec;13(6):829-39. doi: 10.1586/14737167.2013.842127. Epub 2013 Nov 1. Expert Rev Pharmacoecon Outcomes Res. 2013. PMID: 24175733
-
Risk selection in a regulated health insurance market: a review of the concept, possibilities and effects.Expert Rev Pharmacoecon Outcomes Res. 2013 Dec;13(6):743-52. doi: 10.1586/14737167.2013.841546. Expert Rev Pharmacoecon Outcomes Res. 2013. PMID: 24219050 Review.
-
Managing risk selection incentives in health sector reforms.Int J Health Plann Manage. 1999 Oct-Dec;14(4):287-311. doi: 10.1002/(SICI)1099-1751(199910/12)14:4<287::AID-HPM560>3.0.CO;2-V. Int J Health Plann Manage. 1999. PMID: 11184915 Review.
Cited by
-
"Managed competition" for Ireland? The single versus multiple payer debate.BMC Health Serv Res. 2014 Sep 26;14:442. doi: 10.1186/1472-6963-14-442. BMC Health Serv Res. 2014. PMID: 25261074 Free PMC article.
-
Disease prevention: saving lives or reducing health care costs?PLoS One. 2014 Aug 12;9(8):e104469. doi: 10.1371/journal.pone.0104469. eCollection 2014. PLoS One. 2014. PMID: 25116681 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous